首页|宣白承气汤联合布地奈德雾化治疗急性支气管哮喘的疗效及对肺功能、血清IL-4、IFN-γ、CRP的影响

宣白承气汤联合布地奈德雾化治疗急性支气管哮喘的疗效及对肺功能、血清IL-4、IFN-γ、CRP的影响

扫码查看
目的 观察宣白承气汤联合布地奈德雾化治疗急性支气管哮喘的疗效及对患者肺功能、白细胞介素-4(血清IL-4)、γ干扰素(IFN-γ)、C-反应蛋白(CRP)的影响.方法 选取2020年3月-2023年3月收治的98例急性支气管哮喘患者,随机分为对照组与联用组各49例,对照组在常规治疗基础上给予布地奈德雾化治疗,联用组在对照度基础上联用宣白承气汤治疗,疗程均为7 d.对比两组疗效、中医证候积分、肺功能、血清炎症因子水平及不良反应发生情况.结果 治疗7 d后,联用组的疗效等级及总有效率均高于对照组(P<0.05);两组各项主次证证候积分均降低(P<0.05),且联用组均明显低于对照组(P<0.05);两组用力肺活量(FVC)、第1秒用力呼气容积(FEV1)及最大呼气流速(PEF)均升高(P<0.05),且联用组均高于对照组(P<0.05);两组血清IL-4、CRP水平均降低,且联用组低于对照组(P<0.05);IFN-γ水平均升高,且联用组高于对照组(P<0.05).治疗期间,两组不良反应发生率比较无统计学意义(P>0.05).结论 宣白承气汤联合布地奈德雾化治疗急性支气管哮喘疗效显著,可有效改善患者中医症状,减轻炎症反应,改善肺功能.
Efficacy of Xuanbai Chengqi Decoction(宣白承气汤)Combined with Budesonide Atomization on Acute Bronchial Asthma and Its Influence on Lung Function,Serum IL-4,IFN-γ and CRP
Objective To observe the efficacy of Xuanbai Chengqi Decoction(宣白承气汤)combined with budesonide atomi-zation in the treatment of acute bronchial asthma and the influence on lung function,serum interleukin-4(IL-4),interferon γ(IFN-γ)and C-reactive protein(CRP).Methods Ninety-eight patients with acute bronchial asthma who were treated in the hospital from March 2020 to March 2023 were selected and randomly divided into control group and combined group,with 49 ca-ses in each group.The control group was given budesonide atomization therapy on the basis of conventional treatment,and the combined group was treated with Xuanbai Chengqi Decoction on the basis of the control group,and both groups were treated for 7 days.The efficacy,TCM syndromes scores,lung function,serum inflammatory factor levels and occurrence of adverse reactions were compared between the two groups.Results After 7 days of treatment,the efficacy grading and total effective rate in the com-bined group were higher than those in the control group(P<0.05).The scores of primary and secondary syndromes in both groups were decreased(P<0.05),and the scores were significantly lower in the combined group than those in the control group(P<0.05).The values of forced vital capacity(FVC),forced expiratory volume in 1 second(FEV1)and peak expiratory flow rate(PEF)were increased in both groups(P<0.05),and the above indicators in the combined group were higher compared with those in the control group(P<0.05).Serum IL-4 and CRP levels in the two groups were reduced,and the levels in the com-bined group were lower than those in the control group(P<0.05).The IFN-γ level was increased,and the level was higher in the combined group compared to that in the control group(P<0.05).During treatment,there were no statistical differences in the incidence rates of adverse reactions between the two groups(P>0.05).Conclusion Xuanbai Chengqi Decoction combined with budesonide atomization has a significant efficacy in the treatment of acute bronchial asthma,and it can effectively improve the TCM symptoms,relieve the inflammatory response and improve the lung function.

acute bronchial asthmaXuanbai Chengqi Decoction(宣白承气汤)budesonidelung functionefficacy

李莹、姚军丽、赵娜

展开 >

天津职业病防治院(工人医院),天津 300011

急性支气管哮喘 宣白承气汤 布地奈德 肺功能 疗效

2025

辽宁中医杂志
辽宁中医药大学,辽宁省中医药学会

辽宁中医杂志

北大核心
影响因子:0.815
ISSN:1000-1719
年,卷(期):2025.52(1)